Who Should NOT Take Mounjaro: Contraindications & Safety Warnings
Critical safety information about who cannot take Mounjaro. Absolute contraindications, medical conditions requiring caution, drug interactions, pregnancy warnings, and when to avoid this medication.
Why These Contraindications Exist
Thyroid Cancer Risk
The concern: In rodent studies, tirzepatide (and other GLP-1 drugs) caused thyroid C-cell tumours at high doses. This included medullary thyroid carcinoma (MTC).
Human risk: Unknown if this translates to humans, but regulatory agencies mandate warnings. If you or family members have had MTC or MEN2, risk is too high.
Symptoms to watch (all users): Lump in neck, hoarseness, difficulty swallowing, persistent cough—report immediately to doctor.
Pregnancy & Breastfeeding
Pregnancy: Mounjaro causes weight loss—this can harm fetal development. Additionally, tirzepatide safety in pregnancy is not established. Stop at least 2 months before planned conception.
Contraception: Use reliable birth control while taking Mounjaro. Oral contraceptives may be less effective initially (discuss with doctor).
Breastfeeding: Unknown if tirzepatide passes into breast milk. Not recommended while nursing. Discuss alternatives with doctor.
Allergy to Tirzepatide
Symptoms of allergic reaction: Rash, itching, swelling (especially face/throat/tongue), severe dizziness, difficulty breathing.
Action if allergic reaction occurs: Stop medication immediately and seek emergency medical help. Do not take subsequent doses.
Note: Mild injection site reactions (redness, itching) are common and NOT the same as systemic allergy. Discuss with doctor to differentiate.
Conditions Requiring Extreme Caution (Not Absolute Contraindications)
The following conditions don't necessarily prevent Mounjaro use, but require careful evaluation and close monitoring by your doctor:
⚠️ Severe Gastroparesis (Stomach Paralysis)
Mounjaro slows gastric emptying—this is part of how it works. However, if you have severe pre-existing gastroparesis (delayed stomach emptying), Mounjaro could worsen it significantly.
Symptoms: Severe bloating, persistent nausea/vomiting, early satiety, abdominal pain.
Action: Discuss with doctor. May need alternative weight loss approach or very careful dose titration with close monitoring.
⚠️ History of Pancreatitis
GLP-1 medications have rare association with pancreatitis. If you've had previous pancreatitis (especially severe or recurrent), risk may be elevated.
Doctor's decision: May still prescribe if benefits outweigh risks, but will monitor closely for symptoms (severe abdominal pain radiating to back).
Action if symptoms occur: Stop Mounjaro immediately and seek emergency care. Pancreatitis is serious.
⚠️ Diabetic Retinopathy (Eye Disease from Diabetes)
Rapid blood sugar improvement can temporarily worsen diabetic retinopathy. If you have existing diabetic eye disease, rapid glucose control from Mounjaro may paradoxically worsen it initially.
Doctor's approach: Still may prescribe, but will escalate dose more slowly and ensure regular eye examinations.
Action: Report any vision changes immediately—blurred vision, floaters, flashes of light, vision loss.
⚠️ Kidney Disease (Renal Impairment)
Mounjaro itself doesn't directly harm kidneys, but dehydration from GI side effects (vomiting, diarrhoea) can worsen kidney function.
If you have kidney disease: Doctor will likely prescribe but emphasize hydration. More frequent kidney function monitoring (blood tests). May start at lower dose.
Severe kidney disease (dialysis): Limited data—doctor will weigh risks/benefits carefully.
⚠️ Gallbladder Problems
Rapid weight loss increases gallstone risk. If you have history of gallstones or gallbladder disease, risk is elevated on Mounjaro.
Symptoms to watch: Severe right-upper abdominal pain (especially after eating), nausea, vomiting, yellowing of skin/eyes.
Doctor may: Monitor more closely, recommend ultrasound if symptoms, or discuss preventive strategies.
Drug Interactions: What NOT to Mix with Mounjaro
| Medication Type | Interaction | Severity | Action Required |
|---|---|---|---|
| Insulin | Increased risk of hypoglycaemia (low blood sugar) | HIGH | Insulin dose MUST be reduced when starting Mounjaro. Close glucose monitoring required. |
| Sulfonylureas (gliclazide, glimepiride) | Increased hypoglycaemia risk | HIGH | Dose reduction or discontinuation usually needed. Doctor will adjust. |
| Oral medications (any) | Delayed absorption due to slowed gastric emptying | MODERATE | Some medications may be less effective. Discuss timing with doctor. Particularly important for time-sensitive meds. |
| Oral contraceptives | Potentially reduced effectiveness in first 4 weeks | MODERATE | Use additional contraception (barrier method) for first month after starting or increasing dose. |
| Warfarin | May alter anticoagulation | MODERATE | More frequent INR monitoring required when starting Mounjaro. |
💡 Important: Always provide your doctor with a complete list of medications (prescription, over-the-counter, supplements, herbal remedies). Even seemingly innocuous supplements can interact.
Age Considerations
Under 18 Years Old
Not approved: Mounjaro is not licensed for use in children or adolescents under 18 in the UK. Safety and effectiveness not established in this age group.
Exceptions: Very rare cases where specialist paediatric endocrinologist might prescribe off-label for severe obesity with complications. This is exceptional and requires specialist oversight.
Over 75 Years Old
Use with caution: Limited data in elderly populations, especially >75 years. Higher risk of dehydration, malnutrition, and medication interactions due to multiple conditions/medications (polypharmacy).
Doctor's approach: More conservative dosing, closer monitoring, emphasis on adequate nutrition and hydration.
BMI Considerations
BMI Below Treatment Threshold
Mounjaro is indicated for obesity (BMI ≥30) or overweight with comorbidity (BMI ≥27). If your BMI is below these thresholds, Mounjaro is not appropriate—weight loss in this range can be harmful.
Exceptions: None. This is not about vanity—medication is for medical need, not cosmetic weight loss.
Extreme Obesity (BMI >50)
Mounjaro can be used but may be considered alongside or before bariatric surgery options. Close medical supervision essential due to higher risk of complications from obesity itself.
Pre-Existing Mental Health Conditions
Emerging data suggests possible link between GLP-1 medications and mood changes, including depression and suicidal ideation in rare cases.
If you have history of:
- Depression
- Anxiety disorders
- Suicidal thoughts/attempts
- Eating disorders (especially bulimia, anorexia)
Action: Inform your doctor. Not necessarily a contraindication, but requires discussion and monitoring. Report any worsening mood, unusual thoughts, or behavioural changes immediately.
Before Starting Mounjaro: Safety Checklist
Discuss with Your Doctor If You Have:
Frequently Asked Questions
Do NOT take Mounjaro if you have: personal/family history of medullary thyroid cancer or MEN2 syndrome, are pregnant/breastfeeding, have severe gastroparesis, or are allergic to tirzepatide. Use extreme caution if you have: previous pancreatitis, diabetic retinopathy, severe kidney disease, gallbladder problems, or take insulin/sulfonylureas (requires dose adjustment).
No. Mounjaro is contraindicated in pregnancy. Stop at least 2 months before planned conception. Weight loss during pregnancy can harm the baby, and tirzepatide safety in pregnancy is not established. Use reliable contraception while taking Mounjaro. If you become pregnant, stop immediately and contact your doctor.
Depends on the medication. Mounjaro can be combined with metformin safely. However, insulin and sulfonylureas (gliclazide, glimepiride) require dose reductions to prevent dangerous hypoglycaemia. Your doctor MUST adjust these medications when starting Mounjaro. Never adjust diabetes medications yourself.
Requires careful consideration. History of pancreatitis is not an absolute contraindication, but increases risk of recurrence on Mounjaro. Your doctor will weigh severity of previous pancreatitis, cause, and current obesity-related risks. If prescribed, you'll be monitored closely and instructed to stop immediately if severe abdominal pain occurs.
Depends on the type. General thyroid issues (hypothyroidism, hyperthyroidism, nodules) are usually fine—Mounjaro can be used. However, personal or family history of medullary thyroid cancer (MTC) or MEN2 syndrome is an absolute contraindication. Discuss your specific thyroid history with your doctor.
Stop immediately and seek medical help if you experience: severe rash, swelling of face/throat/tongue, difficulty breathing, severe dizziness. Do not take subsequent doses. Alternatives include Wegovy (semaglutide), though cross-reactivity is possible if allergy is to GLP-1 class. Discuss non-GLP-1 weight loss options with doctor.
The Bottom Line
Mounjaro is safe and effective for the vast majority of people with obesity or overweight with complications. However, like all medications, it has contraindications and situations requiring caution.
The most critical absolute contraindications are: thyroid cancer history (MTC/MEN2), pregnancy/breastfeeding, and allergy to tirzepatide. Other conditions require careful evaluation but aren't necessarily prohibitive.
Never self-prescribe or obtain Mounjaro without proper medical assessment. A qualified prescriber will review your medical history, current medications, and individual circumstances to determine if Mounjaro is safe and appropriate for you.
If you have any of the conditions mentioned, don't be discouraged—many can still use Mounjaro with proper monitoring. The key is full disclosure to your doctor and following their guidance.
⚠️ Medical Disclaimer: This information is educational only and not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting Mounjaro. Only your doctor can determine if Mounjaro is safe for your specific circumstances. Do not withhold medical history from your prescriber—full disclosure is essential for your safety.
Recent News About Safety & Regulation
This guide is regularly reviewed. Here's what's changed recently in the UK: